Bruker Daltonics, Ciphergen Biosystems, LSBC, Correlogic Systems, Quest Diagnostics, Laboratory Corporation of America, Oxford GlycoSciences, SurroMed, UC Davis, Pieris Proteolab | GenomeWeb

Bruker Reports Strong Q3, Considerable TOF/TOF Sales to Academic Institutions

Having spilled some of its goodies already in an October presentation at an investors’ meeting (see ProteoMonitor, 10-21-02), Bruker Daltonics formally reported last week that its revenues were up 22 percent for the third quarter. These revenues totaled $29.7 million, compared to $23.8 million in the third quarter of 2001. The company’s net income totaled $1.7 million, up from $925,000 in the previous year’s third quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.